BNP Paribas SA (BNP.SW)
| Previous close | N/A |
| Open | N/A |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | N/A - N/A |
| 52-week range | 60.00 - 60.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 57.903B |
| Beta (5Y monthly) | 1.62 |
| PE ratio (TTM) | 6.09 |
| EPS (TTM) | 7.62 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
BloombergBrevan Howard Cuts More Than 100 Staff in Restructuring Push
(Bloomberg) -- Brevan Howard Asset Management is cutting around 10% of its workforce — or about 100 employees — to reduce costs as one of the world’s best known hedge funds streamlines its rapidly growing operation.Most Read from BloombergElon Wants His Money BackDubai Grinds to Standstill as Flooding Hits CityRecord Rainfall in Dubai? Blame Climate Change, Not Cloud SeedingIsrael Launches Retaliatory Strike on Iran, US Officials SaySingapore Loses ‘World’s Best Airport’ Crown to QatarThe cuts i
Globe NewswireBNP PARIBAS Group: Share buyback - declaration of transactions in own shares from 8 April to 12 April 2024
BNP Paribas share buyback programme Declaration of transactions in own sharesfrom April 8, 2024 to April 12, 2024 Press releaseParis, 15 April 2024 In accordance with Article 5 of Regulation (EU) No 596/2014 on Market Abuse and Article 3 (3) of Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 through regulatory technical standards concerning the conditions applicable to buyback programs and stabilization measures, BNP Paribas informs the market of the following trans
GlobeNewswireBNP Paribas has signed an agreement with Fosun Group to acquire its stake in ageas
BNP Paribas has signed an agreement with Fosun Group to acquire its stake in ageas Press Release Paris, 14 April 2024 BNP Paribas Group announces the signature, through its insurance subsidiary BNP Paribas Cardif, of an agreement to acquire Fosun Group’s stake of approximately 9% in ageas. The acquisition will be performed in two tranches:• 4.8% of the issued shares in the coming days• The balance following the receipt of mandatory regulatory approvals. The total consideration is estimated to ap
